| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 14 |
| 1 | ASPIRIN | 13 |
| 2 | ASPIRIN 325 MG | 12 |
| 3 | ASPIRIN 81 MG | 12 |
| 4 | DIGOXIN | 10 |
| 5 | CARVEDILOL | 9 |
| 6 | ATORVASTATIN CALCIUM | 8 |
| 7 | CLOPIDOGREL | 6 |
| 8 | LISINOPRIL | 6 |
| 9 | SPIRONOLACTONE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 1 | DOFETILIDE | 5 | 0.0005 |
| 2 | FOSINOPIRL SODIUM | 1 | 0.0005 |
| 3 | AMLODIPINE AND ATORVASTATIN | 1 | 0.0002 |
| 4 | FOSINOPRIL | 1 | 0.0002 |
| 5 | AGALSIDASE BETA | 2 | 0.0002 |
| 6 | CILOSTAZOL | 1 | 0.0002 |
| 7 | DIGOXIN | 10 | 0.0001 |
| 8 | GLYBURIDE | 3 | 0.0001 |
| 9 | FONDAPARINUX SODIUM | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 15 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 3 | beta-Adrenergic Blocker [EPC] | 11 |
| 4 | Cardiac Glycoside [EPC] | 10 |
| 5 | alpha-Adrenergic Blocker [EPC] | 9 |
| 6 | Aldosterone Antagonist [EPC] | 7 |
| 7 | Antiarrhythmic [EPC] | 5 |
| 8 | Benzodiazepine [EPC] | 5 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 2 | 0.0002 |
| 1 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Cardiac Glycoside [EPC] | 10 | 0.0001 |
| 3 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 2 | 0.0001 |
| 4 | alpha-Adrenergic Blocker [EPC] | 9 | 0.0001 |
| 5 | Antiarrhythmic [EPC] | 5 | 0.0001 |
| 6 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 7 | Aldosterone Antagonist [EPC] | 7 | 0.0000 |
| 8 | Alkaloid [EPC] | 1 | 0.0000 |
| 9 | beta-Adrenergic Blocker [EPC] | 11 | 0.0000 |